T46 — Poisoning by, adverse effect of and underdosing of agents primarily affecting the cardiovascular system
Is T46 billable?
No — T46 is a non-billable header code. T46 groups more specific codes and cannot be submitted on a claim. A valid ICD-10-CM code must be reported at the highest level of specificity available in its branch. Select one of the 60 billable codes beneath T46.
Billable codes under this header
- T46.0X1APoisoning by cardiac-stimulant glycosides and drugs of similar action, accidental (unintentional), initial encounter
- T46.0X1DPoisoning by cardiac-stimulant glycosides and drugs of similar action, accidental (unintentional), subsequent encounter
- T46.0X1SPoisoning by cardiac-stimulant glycosides and drugs of similar action, accidental (unintentional), sequela
- T46.0X2APoisoning by cardiac-stimulant glycosides and drugs of similar action, intentional self-harm, initial encounter
- T46.0X2DPoisoning by cardiac-stimulant glycosides and drugs of similar action, intentional self-harm, subsequent encounter
- T46.0X2SPoisoning by cardiac-stimulant glycosides and drugs of similar action, intentional self-harm, sequela
- T46.0X3APoisoning by cardiac-stimulant glycosides and drugs of similar action, assault, initial encounter
- T46.0X3DPoisoning by cardiac-stimulant glycosides and drugs of similar action, assault, subsequent encounter
- T46.0X3SPoisoning by cardiac-stimulant glycosides and drugs of similar action, assault, sequela
- T46.0X4APoisoning by cardiac-stimulant glycosides and drugs of similar action, undetermined, initial encounter
- T46.0X4DPoisoning by cardiac-stimulant glycosides and drugs of similar action, undetermined, subsequent encounter
- T46.0X4SPoisoning by cardiac-stimulant glycosides and drugs of similar action, undetermined, sequela
- T46.0X5AAdverse effect of cardiac-stimulant glycosides and drugs of similar action, initial encounter
- T46.0X5DAdverse effect of cardiac-stimulant glycosides and drugs of similar action, subsequent encounter
- T46.0X5SAdverse effect of cardiac-stimulant glycosides and drugs of similar action, sequela
- T46.0X6AUnderdosing of cardiac-stimulant glycosides and drugs of similar action, initial encounter
- T46.0X6DUnderdosing of cardiac-stimulant glycosides and drugs of similar action, subsequent encounter
- T46.0X6SUnderdosing of cardiac-stimulant glycosides and drugs of similar action, sequela
- T46.1X1APoisoning by calcium-channel blockers, accidental (unintentional), initial encounter
- T46.1X1DPoisoning by calcium-channel blockers, accidental (unintentional), subsequent encounter
- T46.1X1SPoisoning by calcium-channel blockers, accidental (unintentional), sequela
- T46.1X2APoisoning by calcium-channel blockers, intentional self-harm, initial encounter
- T46.1X2DPoisoning by calcium-channel blockers, intentional self-harm, subsequent encounter
- T46.1X2SPoisoning by calcium-channel blockers, intentional self-harm, sequela
- T46.1X3APoisoning by calcium-channel blockers, assault, initial encounter
- T46.1X3DPoisoning by calcium-channel blockers, assault, subsequent encounter
- T46.1X3SPoisoning by calcium-channel blockers, assault, sequela
- T46.1X4APoisoning by calcium-channel blockers, undetermined, initial encounter
- T46.1X4DPoisoning by calcium-channel blockers, undetermined, subsequent encounter
- T46.1X4SPoisoning by calcium-channel blockers, undetermined, sequela
- T46.1X5AAdverse effect of calcium-channel blockers, initial encounter
- T46.1X5DAdverse effect of calcium-channel blockers, subsequent encounter
- T46.1X5SAdverse effect of calcium-channel blockers, sequela
- T46.1X6AUnderdosing of calcium-channel blockers, initial encounter
- T46.1X6DUnderdosing of calcium-channel blockers, subsequent encounter
- T46.1X6SUnderdosing of calcium-channel blockers, sequela
- T46.2X1APoisoning by other antidysrhythmic drugs, accidental (unintentional), initial encounter
- T46.2X1DPoisoning by other antidysrhythmic drugs, accidental (unintentional), subsequent encounter
- T46.2X1SPoisoning by other antidysrhythmic drugs, accidental (unintentional), sequela
- T46.2X2APoisoning by other antidysrhythmic drugs, intentional self-harm, initial encounter
- T46.2X2DPoisoning by other antidysrhythmic drugs, intentional self-harm, subsequent encounter
- T46.2X2SPoisoning by other antidysrhythmic drugs, intentional self-harm, sequela
- T46.2X3APoisoning by other antidysrhythmic drugs, assault, initial encounter
- T46.2X3DPoisoning by other antidysrhythmic drugs, assault, subsequent encounter
- T46.2X3SPoisoning by other antidysrhythmic drugs, assault, sequela
- T46.2X4APoisoning by other antidysrhythmic drugs, undetermined, initial encounter
- T46.2X4DPoisoning by other antidysrhythmic drugs, undetermined, subsequent encounter
- T46.2X4SPoisoning by other antidysrhythmic drugs, undetermined, sequela
- T46.2X5AAdverse effect of other antidysrhythmic drugs, initial encounter
- T46.2X5DAdverse effect of other antidysrhythmic drugs, subsequent encounter
- T46.2X5SAdverse effect of other antidysrhythmic drugs, sequela
- T46.2X6AUnderdosing of other antidysrhythmic drugs, initial encounter
- T46.2X6DUnderdosing of other antidysrhythmic drugs, subsequent encounter
- T46.2X6SUnderdosing of other antidysrhythmic drugs, sequela
- T46.3X1APoisoning by coronary vasodilators, accidental (unintentional), initial encounter
- T46.3X1DPoisoning by coronary vasodilators, accidental (unintentional), subsequent encounter
- T46.3X1SPoisoning by coronary vasodilators, accidental (unintentional), sequela
- T46.3X2APoisoning by coronary vasodilators, intentional self-harm, initial encounter
- T46.3X2DPoisoning by coronary vasodilators, intentional self-harm, subsequent encounter
- T46.3X2SPoisoning by coronary vasodilators, intentional self-harm, sequela
T46 at a glance
| Code | T46 |
|---|---|
| Description | Poisoning by, adverse effect of and underdosing of agents primarily affecting the cardiovascular system |
| Billable | No — header code |
| Code set | ICD-10-CM FY2027 |
| Valid for encounters | October 1, 2026 – September 30, 2027 |
Excludes1 — never code together
The conditions below can never be reported together with T46 on the same claim. An Excludes1 note means the two conditions cannot occur in the same patient, so reporting both is a coding error.
- poisoning by, adverse effect of and underdosing of metaraminol (T44.4)
Excludes1 — never code together — inherited from T36-T50
The conditions below can never be reported together with T46 on the same claim. An Excludes1 note means the two conditions cannot occur in the same patient, so reporting both is a coding error.
- toxic reaction to local anesthesia in pregnancy (O29.3-)
Code first — inherited from T36-T50
The underlying condition below must be sequenced before T46. T46 describes a manifestation and cannot be the principal or first-listed diagnosis.
Use additional code — inherited from Chapter 19
Report an additional code alongside T46 to fully describe the condition. T46 is sequenced first.
- code to identify any retained foreign body, if applicable (Z18.-)
Use additional code — inherited from T36-T50
Report an additional code alongside T46 to fully describe the condition. T46 is sequenced first.
Excludes2 — not included here — inherited from Chapter 19
The conditions below are not part of T46, but a patient may have both at the same time. When documentation supports it, T46 and the excluded code may both be reported.
Excludes2 — not included here — inherited from T36-T50
The conditions below are not part of T46, but a patient may have both at the same time. When documentation supports it, T46 and the excluded code may both be reported.
What codes fall under T46? (10)
- T46.0Poisoning by, adverse effect of and underdosing of cardiac-stimulant glycosides and drugs of similar actionnot billable
- T46.1Poisoning by, adverse effect of and underdosing of calcium-channel blockersnot billable
- T46.2Poisoning by, adverse effect of and underdosing of other antidysrhythmic drugs, not elsewhere classifiednot billable
- T46.3Poisoning by, adverse effect of and underdosing of coronary vasodilatorsnot billable
- T46.4Poisoning by, adverse effect of and underdosing of angiotensin-converting-enzyme inhibitorsnot billable
- T46.5Poisoning by, adverse effect of and underdosing of other antihypertensive drugsnot billable
- T46.6Poisoning by, adverse effect of and underdosing of antihyperlipidemic and antiarteriosclerotic drugsnot billable
- T46.7Poisoning by, adverse effect of and underdosing of peripheral vasodilatorsnot billable
- T46.8Poisoning by, adverse effect of and underdosing of antivaricose drugs, including sclerosing agentsnot billable
- T46.9Poisoning by, adverse effect of and underdosing of other and unspecified agents primarily affecting the cardiovascular systemnot billable
How long has T46 existed?
T46 has been in ICD-10-CM since at least FY2016, the earliest fiscal year on record here.
Derived from the official order files for FY2016–FY2026. FY2017 and FY2020 publish no order file, so those years are not covered.